Sarah Isabel Sheikh talks to Neurodegenerative Disease Management about her research into the development of neuroregenerative-based therapies for multiple sclerosis.
In this edition of NCTalks, we speak to Robyn Klein as part of our Spotlight on neuroimmunology – Robyn discusses her research, how inflammatory processes contribute to neurologic disease, and whether immunology and inflammation could be the basis of an eventual preventative treatment for neurodegenerative disease.
This Spotlight will explore every corner of neuroimmunology, looking in-depth at the history of the field, new uses for the immune system in a wealth of neurological diseases, and looking ahead at the future of this ever-expanding field.
A retrospective review of medical records reveals that the presence of a novel autoantibody in a patient’s serum is indicative of autoimmune meningoencephalomyelitis.
In this editorial, the authors focus on TBIs that result in brain hemorrhage. On the battlefield, it is likely to be overlooked in favor of more readily visible injuries, yet bleeding and inflammation within the head can cause death or pervasive ongoing psychiatric conditions.
Elucidating the link between the modifiable risk factors of Alzheimer’s disease and neuroinflammation
In this Special Report, the authors highlight the link between select modifiable risk factors and neuroimmune mechanisms, and demonstrate that by controlling microglial activation and neuroinflammation the prevalence of AD may be decreased.
Research demonstrates both neuroinflammation and neuronal damage in rodents, as well as associated deficits in learning and memory.
We speak to David Vigerust, author of ‘Neuroinflammation: a precursor and promoter of oncogenesis’, about his research and the role of trauma in oncogenesis.
This article reviews the potential role of neuroinflammation as a promoter of oncogenesis within the brain, focusing in on traumatic events such as traumatic brain injuries.